Analysis of Inhaled Corticoid Prescriptions in General Medicine

NCT03179826 | Completed

• 2 other identifiers: RECHMPL17-01522017-A01230-53
• Study Type: observational
• Target: 80
• Locations: 1 country
• Sites: 2

Brief Summary

Chronic obstructive pulmonary disease (COPD) and asthma are frequent and disabling pathologies. The general practitioner is often at the front line vis-a-vis screening, diagnosis and treatment of these pathologies. There are currently many treatments available, in particular inhaled corticosteroids, and although the recommendations for management appear to be well codified in theory, the adaptation of drug therapy remains complex in general practice. The prescription of inhaled corticosteroids, often initiated during a general medicine consultation, is not simple. The aim of this study is to analyze the relevance of the prescription of inhaled corticosteroids in primary care and to identify the criteria necessary for the prescription of inhaled corticosteroids available in general practice. The main objective of our study is to evaluate the rate of consultations where all the elements required for guiding the prescription of an inhaled corticoid are available. The secondary objectives are:

• Identify other factors associated with decision-making
• Identify the causes of inhaled corticosteroid stopping (de-prescription)

Conditions

Asthma; Chronic Obstructive Pulmonary Disease

Outcome Measures

Primary Outcomes (1)

• Presence of all factors justifying the prescription of inhaled cortcoids

  The presence (yes/no) of all factors justifying the prescription of inhaled cortcoids as described in the associated market authorization.

  Day 0 (transversal study)

Study Arms (1)

Study population

Adults consulting with one of the participating general practitioners and requiring long term inhaled corticoids and monitoring.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The study population is composed of adults consulting with one of the participating general practitioners and requiring long term inhaled corticoids and monitoring.

You may qualify if:

• Patient with short-term inhaled corticosteroid therapy
• Informed and not opposed to participate in this research

You may not qualify if:

• Patient under judicial or legal protection
• Adults under any kind of guardianship -

Sponsors & Collaborators

• University Hospital, Montpellier: lead

Study Sites (2)

Cabinet de médecine générale

Clapiers, 34830, France

Location

Cabinet de médecine générale

Saint-Martin-de-Londres, 34380, France

Location

MeSH Terms

Conditions

Asthma; Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Arnaud Bourdin, MD, PhD

  Montpellier University Hospitals

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 6, 2017
• First Posted: June 7, 2017
• Study Start: July 13, 2017
• Primary Completion: July 1, 2018
• Study Completion: December 31, 2018
• Last Updated: April 18, 2019

Record last verified: 2019-04

Locations

FR (2)